Literature DB >> 17703245

Paradoxical embolization in an adult cystic fibrosis patient.

Nabil M Al Lawati1, Pearce Wilcox.   

Abstract

Cystic fibrosis patients with an implantable venous access device (IVAD) and a patent foramen ovale (PFO) are at an increased risk of developing paradoxical embolism. A 33-year-old patient who had a cerebrovascular accident in the above setting is described. She had been anticoagulated because she had thrombosis of the tip of the indwelling catheter, and her PFO was closed percutaneously followed by replacement of her IVAD. She made a full neurological recovery. Echocardiography and prophylactic closure of the PFO, when present, as primary prevention for paradoxical embolism may be warranted in cystic fibrosis patients before placement of an IVAD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17703245      PMCID: PMC2676396          DOI: 10.1155/2007/492128

Source DB:  PubMed          Journal:  Can Respir J        ISSN: 1198-2241            Impact factor:   2.409


  11 in total

Review 1.  Closure of patent foramen ovale: technique, pitfalls, complications, and follow up.

Authors:  B Meier
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

Review 2.  Patent foramen ovale: current pathology, pathophysiology, and clinical status.

Authors:  Hidehiko Hara; Renu Virmani; Elena Ladich; Shannon Mackey-Bojack; Jack Titus; Mark Reisman; William Gray; Masato Nakamura; Michael Mooney; Anil Poulose; Robert S Schwartz
Journal:  J Am Coll Cardiol       Date:  2005-09-29       Impact factor: 24.094

3.  Thromboembolism related to a Port-a-Cath device in a patient with cystic fibrosis.

Authors:  B Yung; J S Elborn; I A Campbell; Y Summers; M Beckles; A A Woodcock
Journal:  Thorax       Date:  1997-01       Impact factor: 9.139

4.  Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both.

Authors:  J L Mas; C Arquizan; C Lamy; M Zuber; L Cabanes; G Derumeaux; J Coste
Journal:  N Engl J Med       Date:  2001-12-13       Impact factor: 91.245

5.  Paradoxical embolization in an adult patient with cystic fibrosis.

Authors:  J D Espiritu; M E Kleinhenz
Journal:  Mayo Clin Proc       Date:  2000-10       Impact factor: 7.616

6.  Complications of indwelling catheters in cystic fibrosis: a 10-year review.

Authors:  M L Aitken; M R Tonelli
Journal:  Chest       Date:  2000-12       Impact factor: 9.410

Review 7.  Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients.

Authors:  Ulrike Krumsdorf; Stefan Ostermayer; Kai Billinger; Thomas Trepels; Elisabeth Zadan; Kathrin Horvath; Horst Sievert
Journal:  J Am Coll Cardiol       Date:  2004-01-21       Impact factor: 24.094

8.  Incidence of thrombus formation on the CardioSEAL and the Amplatzer interatrial closure devices.

Authors:  Hitoshi Anzai; John Child; Barbara Natterson; Janine Krivokapich; Michael C Fishbein; Vicki K Chan; Jonathan M Tobis
Journal:  Am J Cardiol       Date:  2004-02-15       Impact factor: 2.778

9.  Acute neurological deficits in a young adult with cystic fibrosis.

Authors:  Suchada Sritippayawan; Eithne F MacLaughlin; Marlyn S Woo
Journal:  Pediatr Pulmonol       Date:  2003-02

10.  Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism.

Authors:  Francisco Martín; Pedro L Sánchez; Elizabeth Doherty; Pedro J Colon-Hernandez; Gabriel Delgado; Ignacio Inglessis; Nandita Scott; Judy Hung; Mary Etta E King; Ferdinando Buonanno; Zareh Demirjian; Michael de Moor; Igor F Palacios
Journal:  Circulation       Date:  2002-08-27       Impact factor: 29.690

View more
  2 in total

1.  Improvement in pulmonary function following closure of a patent foramen ovale in a man with cystic fibrosis.

Authors:  M Belton; K M Gyi
Journal:  J R Soc Med       Date:  2009-07       Impact factor: 5.344

Review 2.  Increased vigilance needed for the detection of thrombotic complications of central venous access in adolescent cystic fibrosis patients.

Authors:  Nandini Kandamany; Basil Elnazir; Peter Greally
Journal:  Front Pediatr       Date:  2014-11-19       Impact factor: 3.418

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.